"10.1371_journal.pmed.1001657","plos medicine","2014-06-03T00:00:00Z","Miguel W Tregnaghi; Xavier Sáez-Llorens; Pio López; Hector Abate; Enrique Smith; Adriana Pósleman; Arlene Calvo; Digna Wong; Carlos Cortes-Barbosa; Ana Ceballos; Marcelo Tregnaghi; Alexandra Sierra; Mirna Rodriguez; Marisol Troitiño; Carlos Carabajal; Andrea Falaschi; Ana Leandro; Maria Mercedes Castrejón; Alejandro Lepetic; Patricia Lommel; William P Hausdorff; Dorota Borys; Javier Ruiz Guiñazú; Eduardo Ortega-Barría; Juan P Yarzábal; Lode Schuerman; on behalf of the COMPAS Group","Centro de Desarrollo del Proyectos Avanzados en Pediatría, Córdoba, Argentina; Department of Infectious Diseases, Hospital del Niño, Panama City, Panama; Centro de Estudios en Infectología Pediátrica, Cali, Colombia; Department of Infectious Diseases, Hospital Notti, Mendoza, Argentina; Centro de Desarrollo del Proyectos Avanzados en Pediatría, Santiago del Estero, Argentina; Centro de Desarrollo del Proyectos Avanzados en Pediatría, San Juan, Argentina; Health Research International, Panama City, Panama; Instituto de Investigaciones Científicas y Servicios de Alta Tecnología, Panama City, Panama; Department of Pediatrics, Hospital del Niño, Panama City, Panama; GlaxoSmithKline Vaccines, Panama City, Panama; GlaxoSmithKline Vaccines, Buenos Aires, Argentina; GlaxoSmithKline Vaccines, Wavre, Belgium","Conceived and designed the experiments: MWT XSL HA ES AC DW MT MR CC AF MMC ALe PLom WPH DB JRG EOB JPY LS. Performed the experiments: MWT XSL PL HA ES AP AC DW CCB AC MT AS MR MTro CC AF AL MMC ALe. Analyzed the data: MWT XSL HA ES AC DW MT MR CC AF MMC ALe PLom WPH DB JRG EOB JPY LS. Wrote the first draft of the manuscript: MWT XSL PL PLO WPH DB JRG EOB JPY LS. Contributed to the writing of the manuscript: MWT XSL PL HA ES AP AC DW CCB ACe MT AS MR MTro CC AF AL MMC ALe PLom WPH DB JRG EOB JPY LS. ICMJE criteria for authorship read and met: MWT XSL PL HA ES AP AC DW CCB ACe MT AS MR MTro CC AF AL MMC ALe PLom WPH DB JRG EOB JPY LS. Agree with manuscript results and conclusions: MWT XSL PL HA ES AP AC DW CCB ACe MT AS MR MTro CC AF AL MMC ALe PLom WPH DB JRG EOB JPY LS. Enrolled patients: XSL MWT PL HA ES AP AC DW CCB AC MT AS MR MTro CC AF AL. Contributed to the design, execution, and interpretation of statistical analyses: MWT XSL AC AL PLom WPH DB JRG JPY LS. Supervised the research: MWT XSL PL ES AP AC DW CCB ACe AS MR MTro AL CC AF MMC ALe EOB.","I have read the journals policy and have the following conflicts: M.W.T., H.A., E.S., A.P., D.W., C.C.B., A.C., M.T., A.S., M.R., M.Tro., A.L., C.C., and A.F. declare having no conflicts of interest. X.S.-L declares having received support for travel to meetings from the study sponsor. P.L. and A. Ca. declare their institutions received support for travel to meetings and grants from the study sponsor. A. Ca. declares her institution received consulting fee/honoraria from the study sponsor. X.S.-L declares his institution received grant from Health Research International. W.P.H. is a patent co-holder for PCV13 (no royalties). M.M.C., A.Le., P.Lom., W.P.H., D.B., J.R.G., E.O.B., J.P.Y., and L.S. are employed by the GlaxoSmithKline group of companies and own stock/stock options from the GlaxoSmithKline group of companies.","2014","06","Miguel W Tregnaghi","MWT",27,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
